Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 25, 2022

SELL
$2.33 - $3.37 $696 - $1,007
-299 Closed
0 $0
Q3 2021

Oct 28, 2021

SELL
$2.52 - $2.99 $967 - $1,148
-384 Reduced 56.22%
299 $1,000
Q1 2021

Apr 30, 2021

SELL
$2.73 - $4.5 $1,695 - $2,794
-621 Reduced 47.62%
683 $2,000
Q4 2020

Feb 11, 2021

BUY
$2.6 - $3.32 $1,775 - $2,267
683 Added 109.98%
1,304 $3,000
Q3 2020

Nov 03, 2020

BUY
$2.46 - $4.27 $1,527 - $2,651
621 New
621 $2,000

Others Institutions Holding MEIP

# of Institutions
1
Shares Held
2K
Call Options Held
0
Put Options Held
0

About MEI Pharma, Inc.


  • Ticker MEIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 133,261,000
  • Market Cap $385M
  • Description
  • MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...
More about MEIP
Track This Portfolio

Track Signaturefd, LLC Portfolio

Follow Signaturefd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.